✦ LIBER ✦

Progenitor cell activation in alcoholic (ALD) and in non-alcholic fatty liver disease (NAFLD): An immunohistochemical and ultrastructural study

✍ Scribed by A.M.T. Durnez; R. De Vos; C. Verslype; T. Roskams

Book ID: 117372138
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 168 KB
Volume: 38
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)80044-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cell Cycle Arrest and Accelerated Telome

Cell Cycle Arrest and Accelerated Telomere Shortening in Non-Alcoholic Fatty Liver Disease (NAFLD)

✍ Aravinthan, Aloysious ;Scarpini, Cinzia ;Tachtatzis, Phaedra M. ;Penrhyn-Lowe, S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 121 KB

1259 CELL CYCLE ARREST AND ACCELERATED T

1259 CELL CYCLE ARREST AND ACCELERATED TELOMERE SHORTENING IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

✍ Aravinthan, A.; Scarpini, C.; Tachtatzis, P.; Penrhyn-Lowe, S.; Verma, S.; Davie 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

1259 CELL CYCLE ARREST AND ACCELERATED T

1259 CELL CYCLE ARREST AND ACCELERATED TELOMERE SHORTENING IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

✍ Aravinthan, A.; Scarpini, C.; Tachtatzis, P.; Penrhyn-Lowe, S.; Verma, S.; Davie 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

## POSTERS were fed a standard diet (SD). Blood and tissue samples were used for histological, biochemical and molecular analyses. HepG2 cells were used as a model to study molecular pathways that control LITAF expression/activity. Results: We found that either LITAF mRNA or protein were enhanced

Nutritional assessment and hepatic fatty

Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study

✍ Johane P. Allard; Elaheh Aghdassi; Saira Mohammed; Maitreyi Raman; Ghazal Avand; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 151 KB

353 ADIPOKINES AND CYTOKINE IN PATIENTS

353 ADIPOKINES AND CYTOKINE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): A CASE CONTROL STUDY

✍ R. Kumar; K. Madan; S. Prakash; S. Khanal; S.D. Gupta; S.K. Acharya 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Enhancer of Zeste Homolog 2 (EZH2) expre

Enhancer of Zeste Homolog 2 (EZH2) expression and activation in in vivo and in vitro non-alcoholic fatty liver disease (NAFLD)

✍ Gnani, D.; Vella, S.; Crudele, A.; Ceccarelli, S.; De Stefanis, C.; Gaspari, S.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB